Global Parkinson's Disease Market - Strategic Insights and Forecasts (2026-2035)

The global Parkinson’s disease market is expected to grow from USD 25.5 billion in 2026 to USD 45.6 billion in 2035, registering a CAGR of 6.7% during the forecast period.

Key growth drivers include an aging global population, improved diagnostic awareness, rising survival rates, and the expansion of specialized movement disorder care centers, all of which are increasing the diagnosed and treated patient population.

Key challenges include the absence of a definitive cure, limited access to neurologists in underserved regions, lack of early-stage biomarkers, and high long-term treatment and care costs.

Major opportunities include early disease detection using biomarkers, expansion of digital monitoring tools, development of disease-modifying therapies, and growth of multidisciplinary care models.

North America and Europe dominate due to aging populations and strong healthcare infrastructure, while Asia Pacific is experiencing the fastest growth due to rapid demographic aging and improving healthcare access.